INEYE THERAPEUTICS, S. A. has received authorization from INFARMED to conduct the formative usability evaluation of the investigational medical device InEye® PEARL®*.
The approval follows a positive assessment by the Portuguese regulatory authorities and ethics committee, confirming compliance with the applicable requirements under Regulation (EU) 2017/745.
This important milestone supports the ongoing development of InEye®PEARL® and reflects INEYE THERAPEUTICS’ commitment to advancing innovative ophthalmic technologies.
*PEARL – Prolonged Eye Administration for Relief and Lubrication
